FLT3 Gene

What the FLT3 Gene Means

The FLT3 gene is a part of your body’s instructions for making a protein that plays a key role in the growth and development of blood cells. This protein, also called CD135 or fms-like tyrosine kinase 3, helps blood stem cells grow and mature properly. When the FLT3 gene works normally, it supports healthy blood cell formation.

However, sometimes the FLT3 gene changes or mutates. These mutations can cause the protein to become overactive, leading to the production of too many immature white blood cells. This abnormal growth is linked to certain blood cancers, especially acute myeloid leukemia (AML), where the bone marrow makes cancerous blood cells that crowd out healthy ones.

Why FLT3 Mutations Matter in Cancer Care

FLT3 mutations are among the most common genetic changes found in AML. They often make the leukemia more aggressive and harder to treat. Because of this, doctors test for FLT3 mutations to better understand the disease and to help choose the best treatment options.

There are targeted drugs designed to block the overactive FLT3 protein. For example, gilteritinib (brand name Xospata) is approved for adults with AML that has returned or did not respond to previous treatments and who have a FLT3 mutation. Midostaurin (Rydapt) is another drug used with chemotherapy for newly diagnosed AML patients with FLT3 mutations. These treatments aim to slow cancer growth by blocking signals that the mutated FLT3 protein sends inside cancer cells.

What Patients Might Hear or See About FLT3

If your doctor mentions the FLT3 gene, it may be in the context of genetic testing of your leukemia cells. You might hear about specific types of mutations, such as internal tandem duplications (ITD), which are common FLT3 mutations linked to AML. You may also hear about drugs like midostaurin or gilteritinib that target these mutations.

FLT3 mutations are not a diagnosis by themselves but part of the detailed information doctors use to understand your leukemia. Your care team may discuss how these mutations affect your treatment plan or whether you qualify for certain clinical trials.

Where FLT3 Appears in Medical Care

The term FLT3 can show up in your lab reports, especially in genetic or molecular testing results. It may also appear in treatment plans, drug information sheets, or clinical trial descriptions. Because FLT3 mutations influence treatment choices, your healthcare providers may refer to this gene when explaining your options or monitoring your response to therapy.

What FLT3 Does Not Automatically Mean

Seeing FLT3 mentioned does not mean you have a specific diagnosis or that a particular treatment is guaranteed. It is one piece of a larger puzzle. Not all AML patients have FLT3 mutations, and even if they do, treatment decisions depend on many factors including overall health, other genetic changes, and personal preferences.

FLT3 mutations also do not mean the cancer is untreatable. Targeted therapies have been developed to address these mutations, and ongoing research continues to improve options.

Questions to Ask Your Care Team

If FLT3 comes up in your care, consider asking: What does my FLT3 test result mean? How does it affect my treatment options? Are there targeted drugs that might help me? What side effects should I expect from these treatments? Is there a clinical trial I should consider? How will you monitor my response to treatment related to FLT3?

Understanding FLT3 in Context

FLT3 is a gene involved in blood cell growth, and mutations in it can influence leukemia behavior and treatment. However, it is important to understand this term as part of your overall medical picture. Always discuss what FLT3 means for your specific case with your healthcare team rather than relying on the term alone.

Safety and Next Steps

This information is educational and not a substitute for medical advice. If FLT3 or related terms appear in your medical records or discussions, the best next step is to ask your care team to explain what it means for your diagnosis, treatment, or follow-up. Understanding your FLT3 status can help you and your doctors make informed decisions together.